Medical device major Medtronic, Inc. 's ( MDT) Endurant AAA stent graft system - used to treat abdominal aortic aneurysms (AAA) - recently demonstrated consistent, long-lasting performance in two ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Final results of the Endurant Stent Graft ...

Medtronic Inc. (NYSE: MDT) today announced the CE (Conformité Européenne) mark and international launch of the Endurant ® II AAA Stent Graft System, which meaningfully expands the options physicians ...

MINNEAPOLIS -- Chosen for nearly one out of every two endovascular abdominal aortic aneurysm (AAA) repairs worldwide, the Endurant II AAA stent graft system from Medtronic, Inc. continues to ...

DUBLIN, Ohio, June 12, 2018 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices ...

Back in April 2015, Medtronic ($MDT) launched a clinical study of its Endurant Evo AAA stent graft system. Now, the company is suspending recruitment on the trial ...

Indicated for Endovascular Treatment of Abdominal Aortic Aneurysms, Medical Device Has Been Used to Treat More Than 6,000 Patients in United States Since December FDA Approval MINNEAPOLIS--(BUSINESS ...

Latest Results from Two Clinical Studies Show Strong Mid-Term Performance of Leading Medical Device for Endovascular Repair of Abdominal Aortic Aneurysms MINNEAPOLIS -- For endovascular repair of ...

Surgeons at the Michael E. DeBakey VA Medical Center (MEDVAMC) recently performed successful groundbreaking minimally invasive vascular procedures on two military Veterans. The surgeons performed the ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global aortic stent grafts market since 2014 and the market is poised to grow by USD 690.09 million during 2020-2024 at a CAGR of over 5% ...